Search

everythinglearnresearchcommunity

for

Search:↓

Transplant success has improved with better immunosuppressive drugs and donor matching.

Over one-third of women experience hair loss, with female-pattern hair loss being most common, and treatments include minoxidil and possibly hair transplantation.

Postinflammatory hyperpigmentation causes dark skin patches and needs personalized treatment.

Cancer therapy can cause various skin problems, including hair loss, skin darkening, painful hand-foot syndrome, and severe skin damage.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

Some drugs can cause hair loss, change hair color and shape, or increase hair growth, and treatment may involve stopping the drug or using specific hair growth treatments.

Some chemotherapy can cause permanent hair loss.

Chemotherapy and bone marrow transplant can cause permanent hair loss.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Chemotherapy often causes patterned hair loss, with some scalp areas more resistant to hair loss than others.

Chemotherapy can cause various skin problems, and recognizing them helps improve patient care.

The conclusion is to use scalp cooling, gentle hair care, and treatments like minoxidil for managing hair loss from chemotherapy, and stresses the need for more research and collaboration in this area.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Plant-based drugs are effective and safe alternatives for managing PCOS symptoms.

Early and personalized treatment for hair loss in young people is crucial to prevent permanent damage and should include psychological support.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Bimatoprost is safe and effective for improving eyebrow hair.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Minoxidil helps treat eyebrow thinning, monilethrix, early hair loss, and shortens chemo-related hair loss.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Hair loss in cancer patients can be related to the cancer itself, treatment, or other conditions, and understanding it is important for diagnosis and patient care.

Increasing ABC transporters in hair follicles may prevent chemotherapy-induced hair loss.